The company is redefining the latest screening method for age-related conditions by using the latest AI and machine learning technologies to process and analyse vast data sets and integrate the analysis with the latest in biological research. A German native, Junkermann has extensive experience in the tech world. She previously http://garrettdrelr.blogdon.net/la-mejor-parte-de-nicole-junkermann-linkedin-28021287